311 papers
Immunology explores the intricate defense systems that keep our bodies safe from infections and disease. This field examines how our immune cells recognize threats, coordinate responses, and maintain a delicate balance between fighting invaders and avoiding self-harm. From understanding vaccine mechanisms to investigating autoimmune disorders, these studies reveal the dynamic biology protecting human health every day.
On Gist.Science, we ensure these critical discoveries remain accessible to everyone. We automatically process every new preprint in this category as it appears on bioRxiv, transforming complex research into both plain-language explanations and detailed technical summaries. This approach allows readers to grasp the core findings without getting lost in dense jargon, while still providing the depth needed for scientific inquiry.
Below are the latest immunology papers from bioRxiv, each accompanied by our curated summaries to help you navigate the newest breakthroughs in the field.
This study presents a calibrated mechanistic mathematical model of the G001 HIV vaccine trial that reveals how class-specific differences in B-cell activation rates and stronger within-class competition shape the magnitude and composition of vaccine-induced humoral immunity, providing a quantitative framework to optimize strategies for expanding broadly neutralizing antibody precursors.
This study demonstrates that sphingosine-1-phosphate (S1P) restrains the formation of lipid-loaded foamy macrophages and modulates associated immunometabolic dysregulation in multidrug-resistant tuberculosis, supporting its potential as a host-directed therapeutic strategy.
This study identifies the HCMV gH/UL116 envelope complex as a promising vaccine candidate by demonstrating that it elicits antibodies capable of both neutralizing viral entry and activating Fc-mediated effector functions through distinct epitopes.
This study identifies proteasome inhibitors as selective potentiators of Type III interferon antiviral immunity by increasing cell-surface IL-10Rβ levels, thereby enhancing JAK-STAT signaling and bridging the efficacy gap between Type III and Type I interferons.
This study demonstrates that systemic autoimmunity drives the expansion and pathogenic differentiation of microbiota-reactive CD4⁺ T cells through altered dendritic cell trafficking, with cells conditioned by the pathobiont *Enterococcus gallinarum* specifically exacerbating disease via IL-21 and IFN-γ-dependent mechanisms.
This study reveals that intraepithelial T cells utilize an atypical, attenuated TCR signaling pathway triggered by BTNL proteins in healthy gut tissues, which prevents destructive activation unless reinforced by co-stimulation or inflammation, thereby allowing these cells to maintain barrier integrity while remaining poised to respond to tissue damage.
This study introduces an image-guided sorting framework to distinguish physically interacting T cell-monocyte doublets from coincidental ones in tuberculosis patients, revealing that true physical contact drives a global program of unidirectional RNA transfer, heightened metabolism, and cytotoxicity distinct from non-interacting or disrupted cell pairs.
This study demonstrates that non-canonical IL-2 signaling (MACS), mediated by a CD25-CCR7 complex, is essential for the differentiation and functional specification of peripheral regulatory T cells in gut-associated lymphoid tissues via an AP-1-dependent transcriptional network, thereby establishing a distinct mechanism for maintaining immune tolerance.
Using a murine model, this study demonstrates that while both hypothermic and normothermic machine perfusion improve upon static cold storage by inducing antioxidant and hypoxia-responsive genes, normothermic perfusion uniquely causes more severe tubular injury, heightened inflammation, and increased immune cell mobilization compared to hypothermic perfusion.
This study demonstrates that maternal microchimerism in infants influences malaria outcomes by modulating the quantity and quality of prenatal immune priming against *Plasmodium falciparum*, specifically by reducing the frequency of protective T-cell populations and shifting the inflammatory response to lower the risk of postnatal parasitemia and febrile malaria.